VAM
Visium Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-792,295
| Closed | -$49.7M | – | 300 |
|
|
2016
Q1 | $49.7M | Buy |
792,295
+690,948
| +682% | +$43.4M | 0.85% | 22 |
|
|
2015
Q4 | $9.54M | Buy |
+101,347
| New | +$9.54M | 0.14% | 161 |
|
|
2015
Q3 | – | Sell |
-93,684
| Closed | -$11.2M | – | 830 |
|
|
2015
Q2 | $11.2M | Buy |
93,684
+87,167
| +1,338% | +$10.4M | 0.16% | 136 |
|
|
2015
Q1 | $681K | Buy |
+6,517
| New | +$681K | 0.01% | 585 |
|